Navigation Links
St. Jude projects 90 percent cure rate for ALL

hildren is especially significant in the case of African-American children, Pui noted. They still have poor outcomes in national studies, but studies at St. Jude have shown African-American children have the same high cure rates as white children when given access to the same effective treatments.

"This reflects the ability of St. Jude to provide free treatment to all children regardless of their ethnic or racial backgrounds or their ability to pay; and to tailor the treatment according to their specific needs," Pui said. "The significant leadership role St. Jude played is due entirely to the enormous contributions made by our extraordinary team of doctors, pharmacists, nurses, and other clinicians and scientists over the years," said William E. Evans, Pharm.D., director and chief executive officer of St. Jude and the paper's co-author. "Their efforts are directly responsible for helping to push up the cure rate for ALL.

"Thanks to their work and the work of other institutions, we can now identify factors putting patients at high risk; and that has enabled us to determine whether treatment failure is due to resistance of leukemic cells to drugs, or merely due to the use of inadequate doses of those agents," Evans said. "By having the tools to precisely assess the risk of relapse in a specific patient, we can design the most effective treatments possible at the start of therapy. That's a key element of our success in raising the cure rate for ALL while limiting toxic effects of therapy."

That success is based to a large extent on the work done at St. Jude and elsewhere in identifying specific mutations in leukemic cells that strongly suggest the likelihood that treatment will fail the child, the authors reported. For example, a chromosomal abnormality called the TEL-AML1 fusion gene, which is an abnormal combination of two separate genes, confers a relatively favorable outlook for patients with this form of ALL. But patients whose leukemic cel
'"/>

Source:St. Jude Children's Research Hospital


Page: 1 2 3 4 5

Related biology news :

1. Disease diagnosis, biodefense among UH chemical research projects
2. Hunger in America rises by 43 percent over last five years
3. Method slashes quantum dot costs by 80 percent
4. Hepatitis B accounts for 40 percent of missing Asian women
5. Vaccine provides 100 percent protection against avian flu virus in animal study
6. Oceans are 70 percent shark free
7. BiovaxID?yields 89 percent survival in patients with aggressive non-Hodgkins
8. Biofuels can replace about 30 percent of fuel needs with significant research and policy effort
9. Psychotropic drug prescriptions for teens surge 250 percent over 7 year period
10. Just the expectation of a mirthful laughter experience boosts endorphins 27 percent, HGH 87 percent
11. Septum keeps neurons in synch, can reduce epileptic seizures by 90 percent
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Jude projects percent cure rate for ALL

(Date:2/12/2015)...   MedNet Solutions , a global life ... systems, has recently bolstered its iMedNet™ ... iMedNet as the eClinical solution of ... consultants.  Building on the Program,s existing benefits (including ... co-marketing opportunities), MedNet,s new and improved program provides ...
(Date:2/11/2015)... 2015 According to ... Market by Product (Cards and Readers, Biometrics, Controllers, Management ... Industrial, Healthcare, Education) and By Geography - Global Forecast and Analysis ... Access Control Market is expected to reach ... CAGR of 10.6% between 2014 and 2020. ...
(Date:2/9/2015)... Texas , Feb. 9, 2015  Lintec of ... fabrication methods for carbon nanotube (CNT) macrostructures, including sheets, ... at Dallas (UTD). Leveraging the vast industrial ... Tokyo, Japan , Lintec of America is ... Richardson, TX , focusing on scaling up ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... by researchers at Hasbro Childrens Hospital, the pediatric division ... York, offers new insight into the role that the ... disease. The cystic fibrosis transmembrane conductance regulator (CFTR) ... Mutations of this protein are associated with cystic fibrosis ...
... which tend to involve localized changes in sea surface ... than the more uniform patterns of global warming, a ... debate over the effect of global warming on hurricanes, ... more favorable environment for hurricane development and intensification. However, ...
... Viejo, California) Ossur, an emerging leader in the ... of integration, is pleased to announce that the Journal ... two year cervical collar study performed by the Mayo ... Interface Pressure from Four Cervical Collars, finds that Ossurs ...
Cached Biology News:Study uncovers clues to cystic fibrosis gene dysfunction and gastrointestinal disease 2Climate's remote control on hurricanes 2Mayo Clinic study: Ossur's collars superior in immobilization and reduction of pressure 2
(Date:2/27/2015)... Mass. , Feb. 27, 2015 ... of the NCATS rare-diseases portfolio " in ... a new financing technique to reduce the risk ... diseases and potentially unlock new levels of funding ... The product of a unique collaboration between scientists ...
(Date:2/27/2015)... 27, 2015  Pfenex Inc. (NYSE MKT: PFNX), a ... therapeutics, today announced that it will be presenting at ... March 2 nd at 3pm PST. Patrick Lucy, chief ... discussing the current state of the biosimilar industry landscape ... For more information on CALBIO 2015 and ...
(Date:2/26/2015)... 26, 2015 S&P Capital IQ (MHFI) announced ... coverage on MabVax Therapeutics Holdings Inc . ... stage biotechnology company focused on the development of vaccine ... the treatment of cancer. MabVax has discovered a pipeline ... immune responses generated by patients who have been immunized ...
(Date:2/26/2015)... 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... Chief Executive Officer of Regulus, will present a company ... Annual Healthcare Conference on Wednesday, March 4, 2015 at ... the Boston Marriott Copley Place.  The ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
... differences among countries. This is what medical researchers ... from biobanks in their research. For one thing, ... international studies. In the latest issue of Nature ... (CBE), together with leading biobank researchers, put forward a ...
... of disease is often critical to how successful treatment can ... is a hot research field, where every small step is ... issue of Molecular & Cellular Proteomics, Uppsala University researchers describe ... Proteins build up the bodys cells and tissues, and our ...
... Washington DC*-- Key components of a new approach to ... Friday as part of a twelve-day, low-Earth orbit experiment ... prelude future journeys to Mars. , The new approach ... pregnancy test kits. The so-called immunoassays are embodied in ...
Cached Biology Technology:Long-awaited international ethical guidelines for biobank researchers 2Life on Mars 'pregnancy test' successfully launched 2